Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Histochemistry|January 1, 1986
Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodiesR Håkanson, G Böttcher, E Ekblad, et al.
Cellular Immunology|January 10, 1997
Allogeneic heart transplantation activates alloreactive NK cellsE Petersson, O Ostraat, H Ekberg, et al.
Bioconjugate Chemistry|November 1, 1993
Preparation and characterization of conjugates of monoclonal antibodies and staphylococcal enterotoxin A using a new hydrophilic cross-linkerE Akerblom, M Dohlsten, C Brynö, et al.
International Journal of Oncology|October 28, 1999
Treatment with tumor-reactive Fab-IL-2 and Fab-staphylococcal enterotoxin A fusion proteins leads to sustained T cell activation, and long-term survival of mice with established tumorsM Søgaard, L Ohlsson, K Kristensson, et al.
European Journal of Immunology|May 1, 1991
Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptorM Dohlsten, G Hedlund, S Segren, et al.
European Journal of Immunology|January 1, 1996
Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinomaM J Litton, M Dohlsten, P A Lando, et al.
Critical Reviews in Immunology|January 1, 1995
T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profilesA G Wingren, E Parra, M Varga, et al.
European Journal of Immunology|January 1, 1991
Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicityM Dohlsten, G Hedlund, P A Lando, et al.
The American Journal of Pathology|May 1, 1997
Tumor therapy with an antibody-targeted superantigen generates a dichotomy between local and systemic immune responsesM J Litton, M Dohlsten, J Hansson, et al.
British Journal of Cancer|July 5, 2001
Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigenG Forsberg, L Ohlsson, T Brodin, et al.
Pageof 15